申请人:Shering Aktiengesellschaft
公开号:US04600715A1
公开(公告)日:1986-07-15
.beta.-carboline derivatives of general Formula I ##STR1## wherein R.sup.3 is ##STR2## wherein R.sup.5 is C.sub.1-5 alkyl, R.sup.6 is lower alkyl, aralkyl, or alkoxyalkyl of up to 7 carbon atoms, and R.sup.7 and R.sup.8 are hydrogen C.sub.1-5 alkyl, or, collectively with the amido nitrogen atom, piperidino, R.sup.4 is hydrogen, C.sub.1-3 alkyl, or CH.sub.2 OR.sup.9 wherein R.sup.9 is C.sub.1-3 alkyl, atoms, and R.sup.A is --COOR.sup.10 ##STR3## wherein R.sup.10 is hydrogen, lower alkyl, alkoxyalkyl or alkenyl of up to 5 carbon atoms, or benzyl, or X is oxygen or sulfur, and R.sup.11 and R.sup.12 each are hydrogen, lower alkyl or alkenyl or, collectively with the amido nitrogen atom, represent a hetero ring, are prepared by conventional methods and exhibit, inter alia, an effect on the central nervous system and are suitable for use as psychopharmaceuticals.
一般式I的.beta.-咔啉衍生物 ##STR1## 其中R.sup.3是 ##STR2## 其中R.sup.5是C.sub.1-5烷基,R.sup.6是下游烷基,芳基烷基或最多7个碳原子的烷氧基烷基,R.sup.7和R.sup.8是氢C.sub.1-5烷基,或与酰胺氮原子一起,哌啶基,R.sup.4是氢,C.sub.1-3烷基或CH.sub.2 OR.sup.9,其中R.sup.9是C.sub.1-3烷基,原子,R.sup.A是--COOR.sup.10 ##STR3## 其中R.sup.10是氢,下游烷基,烷氧基烷基或最多5个碳原子的烯基,苯甲基或X是氧或硫,R.sup.11和R.sup.12分别是氢,下游烷基或烯基或与酰胺氮原子一起,代表杂环,通过常规方法制备,并在中枢神经系统上表现出影响,适用于用作精神药物。